ArticleIn vivo (Athens, Greece)

Clinical Impact of the C-Reactive Protein-Albumin-Lymphocyte Index as a Prognostic Biomarker in Patients With Recurrent Pancreatic Cancer.

Teruhisa Sakamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.